Home/Filings/4/0001567619-20-006630
4//SEC Filing

BAFFI ROBERT 4

Accession 0001567619-20-006630

CIK 0001048477other

Filed

Mar 16, 8:00 PM ET

Accepted

Mar 17, 9:11 PM ET

Size

9.0 KB

Accession

0001567619-20-006630

Insider Transaction Report

Form 4
Period: 2020-03-13
BAFFI ROBERT
SVP, Technial Operations
Transactions
  • Tax Payment

    Common Stock

    2020-03-13$84.50/sh7,600$642,200109,979 total
  • Award

    Common Stock

    2020-03-16+10,660120,639 total
  • Award

    Stock Option (Right to buy Common Stock)

    2020-03-16+30,39030,390 total
    Exercise: $73.82From: 2021-03-16Exp: 2030-03-15Common Stock (30,390 underlying)
Holdings
  • Common Stock

    (indirect: By Trust)
    71,882
Footnotes (2)
  • [F1]Restricted stock units granted on March 16, 2020. Price not applicable.
  • [F2]Option grant vests 12/48th on March 16, 2021 and 1/48th on the 16th day of each month thereafter.

Documents

1 file

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0001274826

Filing Metadata

Form type
4
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 9:11 PM ET
Size
9.0 KB